HomeTagsLepu Biopharma Co Ltd

Tag: Lepu Biopharma Co Ltd

spot_imgspot_img

Lepu Biopharma (2157.HK) announces 2025 interim results

- ADC pipeline with multiple products entering key clinical stages - Revenue increased by 350% year-on-year Focusing on the field of tumor treatment, innovative biopharmaceutical company...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img